Pheochromocytoma physical examination: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(9 intermediate revisions by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
Common physical exam findings of pheochromocytoma include [[tachycardia]], [[hypertension]], and [[orthostatic hypotension]].
Patients with [[pheochromocytoma]] usually appear [[diaphoretic]] and [[anxious]]. Physical examination of patients with [[pheochromocytoma]] is usually remarkable for  [[tachycardia]], [[hypertension]], and [[orthostatic hypotension]].


==Physical Examination==
==Physical Examination==
Physical examination of patients with [[pheochromocytoma]] is usually remarkable for  [[tachycardia]], [[hypertension]], and [[orthostatic hypotension]].


=== Appearance of the Patient ===
=== Appearance of the Patient ===
* Patients may appear tired, weak, [[diaphoretic]] and [[anxious]].<ref name="pmid8325290">{{cite journal| author=Bravo EL, Gifford RW| title=Pheochromocytoma. | journal=Endocrinol Metab Clin North Am | year= 1993 | volume= 22 | issue= 2 | pages= 329-41 | pmid=8325290 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8325290  }}</ref>  
* Patients with [[pheochromocytoma]] usually appear tired, weak, [[diaphoretic]] and [[anxious]].<ref name="pmid8325290">{{cite journal| author=Bravo EL, Gifford RW| title=Pheochromocytoma. | journal=Endocrinol Metab Clin North Am | year= 1993 | volume= 22 | issue= 2 | pages= 329-41 | pmid=8325290 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8325290  }}</ref>
* Patients may appear quite well if the [[disease]] is [[asymptomatic]].
* Patients may appear quite well if the [[disease]] is [[asymptomatic]].
* Patients may appear [[Flushing|flushed]] due to associated increase in [[erythropoietin]] secretion.<ref name="pmid7567437">{{cite journal| author=Drénou B, Le Tulzo Y, Caulet-Maugendre S, Le Guerrier A, Leclercq C, Guilhem I et al.| title=Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion. | journal=Nouv Rev Fr Hematol | year= 1995 | volume= 37 | issue= 3 | pages= 197-9 | pmid=7567437 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7567437  }}</ref>
* Patients may appear [[Flushing|flushed]] due to associated increase in [[erythropoietin]] secretion.<ref name="pmid7567437">{{cite journal| author=Drénou B, Le Tulzo Y, Caulet-Maugendre S, Le Guerrier A, Leclercq C, Guilhem I et al.| title=Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion. | journal=Nouv Rev Fr Hematol | year= 1995 | volume= 37 | issue= 3 | pages= 197-9 | pmid=7567437 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7567437  }}</ref>
* Patients may appear [[obese]] due to associated type2 [[diabetes mellitus]] and [[Cushing's syndrome]].<ref name="pmid12923403">{{cite journal| author=La Batide-Alanore A, Chatellier G, Plouin PF| title=Diabetes as a marker of pheochromocytoma in hypertensive patients. | journal=J Hypertens | year= 2003 | volume= 21 | issue= 9 | pages= 1703-7 | pmid=12923403 | doi=10.1097/01.hjh.0000084729.53355.ce | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12923403  }}</ref>
* Patients may appear [[obese]] due to associated type 2 [[diabetes mellitus]] and [[Cushing's syndrome]].<ref name="pmid12923403">{{cite journal| author=La Batide-Alanore A, Chatellier G, Plouin PF| title=Diabetes as a marker of pheochromocytoma in hypertensive patients. | journal=J Hypertens | year= 2003 | volume= 21 | issue= 9 | pages= 1703-7 | pmid=12923403 | doi=10.1097/01.hjh.0000084729.53355.ce | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12923403  }}</ref>


=== Vital Signs ===
=== Vital Signs ===
* Hyperthermia may be present <ref name="pmid24176474">{{cite journal| author=Tenner AG, Halvorson KM| title=Endocrine causes of dangerous fever. | journal=Emerg Med Clin North Am | year= 2013 | volume= 31 | issue= 4 | pages= 969-86 | pmid=24176474 | doi=10.1016/j.emc.2013.07.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24176474  }} </ref>
* [[Tachycardia]] with a regular pulse. Irregular pulse may occurr in [[supraventricular tachycardia]].
* [[Tachycardia]] with a regular pulse. Irregular pulse may occurr in [[supraventricular tachycardia]].
* [[Tachypnea]] if [[malignant]] secondaries are found in the [[lung]]. [[Dyspnea]] occurs in patients with complicated [[heart failure]] and [[Cardiomyopathy|cardiomyopathy.]]
* [[Tachypnea]] if [[malignant]] secondaries are found in the [[lung]]. [[Dyspnea]] occurs in patients with complicated [[heart failure]] and [[Cardiomyopathy|cardiomyopathy.]]
* Rapid strong equal [[pulse]].
* Rapid strong equal [[pulse]].
* High [[blood pressure]] with normal [[pulse pressure]].
* High [[blood pressure]] with normal [[pulse pressure]].
* [[Hypotension]] occurs due to fluid contraction.  
* [[Hypotension]] occurs due to fluid contraction.


=== Skin ===
=== Skin ===
* [[Jaundice]] secondary to deranged [[liver]] function in case of [[metastasis]] to the [[liver]].
* [[Jaundice]] secondary to deranged [[liver]] function in case of [[metastasis]] to the [[liver]].


=== Head ===
=== HEENT===
* [[Facial flushing]].
* [[Facial flushing]].
* [[Icterus|Scleral icterus]] in case of [[metastasis]] to the [[liver]].
* [[Icterus|Scleral icterus]] in case of [[metastasis]] to the [[liver]].
Line 53: Line 55:
=== Back ===
=== Back ===
* Point [[tenderness]] in [[MEN1]] patients with [[hyperparathyroidism]].
* Point [[tenderness]] in [[MEN1]] patients with [[hyperparathyroidism]].
===Genitourinary===
* Genitourinary examination of patients with [[pheochromocytoma]] is usually normal.
===Neuromuscular===
*Patient is usually oriented to person, place, and time; disorientation may be seen if [[pheochromocytoma]] precipitates [[hypertensive encephalopathy]].
* Altered mental status may be present if [[pheochromocytoma]] precipitates [[hypertensive encephalopathy]]. <ref name="pmid32595044">{{cite journal| author=| title=Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5. | journal=Lancet Infect Dis | year= 2020 | volume= 20 | issue= 7 | pages= e148 | pmid=32595044 | doi=10.1016/S1473-3099(20)30370-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32595044  }} </ref>
*[[Hyperreflexia]] <ref name="pmid475568">{{cite journal| author=Manger WM, Davis SW, Chu DS| title=Autonomic hyperreflexia and its differentiation from pheochromocytoma. | journal=Arch Phys Med Rehabil | year= 1979 | volume= 60 | issue= 4 | pages= 159-61 | pmid=475568 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=475568  }} </ref>
* In case of [[Stroke|acute stroke]] due to paroxysmal [[hypertension]], the following may be seen:
** Corresponding [[Cranial nerves|cranial nerve]] deficit
** Unilateral/bilateral upper/lower [[Weakness|extremity weakness]]
**Unilateral/[[bilateral]] [[sensory loss]] in the upper/lower extremity
*[[Bilateral]] [[tremor]] at rest
===Extremities===
*[[Bilateral]] generalized [[Tremor|tremors]]


==References==
==References==

Latest revision as of 21:16, 28 July 2020

Pheochromocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pheochromocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pheochromocytoma physical examination On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pheochromocytoma physical examination

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pheochromocytoma physical examination

CDC on Pheochromocytoma physical examination

Pheochromocytoma physical examination in the news

Blogs on Pheochromocytoma physical examination

Directions to Hospitals Treating Pheochromocytoma

Risk calculators and risk factors for Pheochromocytoma physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]

Overview

Patients with pheochromocytoma usually appear diaphoretic and anxious. Physical examination of patients with pheochromocytoma is usually remarkable for tachycardia, hypertension, and orthostatic hypotension.

Physical Examination

Physical examination of patients with pheochromocytoma is usually remarkable for tachycardia, hypertension, and orthostatic hypotension.

Appearance of the Patient

Vital Signs

Skin

HEENT

Neck

Lungs

Heart

Abdomen

Back

Genitourinary

Neuromuscular

Extremities

References

  1. Bravo EL, Gifford RW (1993). "Pheochromocytoma". Endocrinol Metab Clin North Am. 22 (2): 329–41. PMID 8325290.
  2. Drénou B, Le Tulzo Y, Caulet-Maugendre S, Le Guerrier A, Leclercq C, Guilhem I; et al. (1995). "Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion". Nouv Rev Fr Hematol. 37 (3): 197–9. PMID 7567437.
  3. La Batide-Alanore A, Chatellier G, Plouin PF (2003). "Diabetes as a marker of pheochromocytoma in hypertensive patients". J Hypertens. 21 (9): 1703–7. doi:10.1097/01.hjh.0000084729.53355.ce. PMID 12923403.
  4. Tenner AG, Halvorson KM (2013). "Endocrine causes of dangerous fever". Emerg Med Clin North Am. 31 (4): 969–86. doi:10.1016/j.emc.2013.07.010. PMID 24176474.
  5. Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM (2008). "Catecholamine-induced cardiomyopathy". Endocr Pract. 14 (9): 1137–49. doi:10.4158/EP.14.9.1137. PMID 19158054.
  6. HEINRICH WA, JUDD ES (1948). "A critical analysis of biopsy of lymph nodes". Proc Staff Meet Mayo Clin. 23 (21): 465–9. PMID 18888946.
  7. Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF; et al. (2015). "Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma". Thyroid. 25 (6): 567–610. doi:10.1089/thy.2014.0335. PMC 4490627. PMID 25810047.
  8. O'Riordain DS, O'Brien T, Crotty TB, Gharib H, Grant CS, van Heerden JA (1995). "Multiple endocrine neoplasia type 2B: more than an endocrine disorder". Surgery. 118 (6): 936–42. PMID 7491537.
  9. Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF; et al. (2015). "Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma". Thyroid. 25 (6): 567–610. doi:10.1089/thy.2014.0335. PMC 4490627. PMID 25810047.
  10. "Correction to Lancet Infectious Diseases 2020; published online April 29. https://doi.org/10.1016/ S1473-3099(20)30064-5". Lancet Infect Dis. 20 (7): e148. 2020. doi:10.1016/S1473-3099(20)30370-4. PMID 32595044 Check |pmid= value (help). External link in |title= (help)
  11. Manger WM, Davis SW, Chu DS (1979). "Autonomic hyperreflexia and its differentiation from pheochromocytoma". Arch Phys Med Rehabil. 60 (4): 159–61. PMID 475568.